side effects of glp 1 agonists GLP-1 Effects: A Complete Guide to What You Can Expect The GLP-1 Agonists and Obesity:
Description
Roberts, D

Szeinbach SL, Barnes JH, Summers KH, Lenox SM

Protein shakes designed for GLP-1 users can help when solid food feels challenging during periods of strong appetite suppression
Journal of Alzheimer's Disease

Additionally, the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity trial demonstrated that semaglutide consistently reduced major cardiovascular event endpoints by approximately 20% compared to placebo over an approximately 3-year follow-up period in patients with overweight or obesity and cardiovascular disease (Table 1), but without diabetes [93]

Studies involving animal subjects
